Cargando…
Inhibition of Ceramide Metabolism Sensitizes Human Leukemia Cells to Inhibition of BCL2-Like Proteins
The identification of novel combinations of effective cancer drugs is required for the successful treatment of cancer patients for a number of reasons. First, many “cancer specific” therapeutics display detrimental patient side-effects and second, there are almost no examples of single agent therape...
Autores principales: | Casson, Lavona, Howell, Lauren, Mathews, Lesley A., Ferrer, Marc, Southall, Noel, Guha, Rajarshi, Keller, Jonathan M., Thomas, Craig, Siskind, Leah J., Beverly, Levi J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546986/ https://www.ncbi.nlm.nih.gov/pubmed/23342165 http://dx.doi.org/10.1371/journal.pone.0054525 |
Ejemplares similares
-
Perturbation of Methionine/S-adenosylmethionine Metabolism as a Novel Vulnerability in MLL Rearranged Leukemia
por: Barve, Aditya, et al.
Publicado: (2019) -
Primary lung cancer samples cultured under microenvironment-mimetic conditions enrich for mesenchymal stem-like cells that promote metastasis
por: Saforo, Douglas, et al.
Publicado: (2019) -
Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia
por: Zhang, Meili, et al.
Publicado: (2015) -
Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor
resistance in acute myeloid leukemia
por: Lewis, Alexander C., et al.
Publicado: (2022) -
Plagiochiline A Inhibits Cytokinetic Abscission and Induces Cell Death
por: Stivers, Nicole S., et al.
Publicado: (2018)